As illustrated in Fig 5, urinary EVs from FSGS patients resulted in greater immunofluorescence intensity of both PCNA and ki67 in human mesangial cells compared to the control EVs after being treated for 6 hours (Fig 5). The gene discussed is MKI67; the disease is focal segmental glomerulosclerosis.